BeneCard PBF, has been awarded the 2023 Excellence Award for Clinical Innovation by the Pharmacy Benefit Management Institute (PBMI) for their     bWell Ahead model. 

The innovative bWell Ahead offering, which encompasses the 2020 Excellence Award winning Care Coordination program, now includes proprietary machine learning technology. This advancement provides clients with the awareness of potential adverse effects ranging from disability to hospitalizations to death that could impact their members, while providing insight into budget considerations through spend predictability.

The foundation of this model, BenePrecise® leverages the science of pharmacogenomics, which makes personalized medication prescribing possible. Based on a member’s metabolism, the program helps reduce trial and error, making it easier to find the right medication, reducing adverse drug reactions (ADRs), and speeding up the realization of therapeutic benefits.